Figure 2.
AST and bilirubin levels. (A) Total serum bilirubin and AST levels are elevated in WT mice receiving L-NAME but not in PAI-1-/- mice or in WT mice receiving tiplaxtinin (PAI-039). (B) Tiplaxtinin (PAI-039) reduced plasma PAI-1 activity in WT mice receiving L-NAME.